Sweden · Research startup
Sweden · Empros Pharma
Empros Pharma AB is a biopharmaceutical company based in Sweden, founded in 2013 by researchers and entrepreneurs from Uppsala University in collaboration with Flerie Invest.
Funding reportedLast round: Series A
About Empros Pharma
Empros Pharma AB is a biopharmaceutical company based in Sweden, founded in 2013 by researchers and entrepreneurs from Uppsala University in collaboration with Flerie Invest.
The company is dedicated to developing EMP16, an oral weight management drug aimed at addressing overweight, obesity, and related conditions such as type 2 diabetes. Empros Pharma has made significant progress with EMP16, successfully completing early-phase trials that demonstrated a strong safety profile and improved blood glucose control. The company has also conducted a Phase IIb trial with positive results regarding efficacy, safety, and tolerability. Plans are in place to initiate Phase III trials in the US by the end of 2024, with data anticipated in 2026 and a potential market launch in early 2027. EMP16 combines the lipase inhibitor orlistat with the glucosidase/amylase inhibitor acarbose, offering a unique approach to obesity treatment.
What company datasets say Empros Pharma raised
Funding, as reported
On a portfolio page
Investors who name them
Each firm lists Empros Pharma on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health caremetabolismpharmaceutical innovationbiotechnology researchmanufacturinginnovative drug formulationoral drugmedical researchcombination therapymetabolic healthclinical researchhospital & health careresearch and developmentmedicalgastrointestinal systemproprietary drug technology
Built with from their website
Google MapsLiteSpeedWordPress.orgFont AwesomeElementorViewport MetaPriority HintsGoogle Font APIimagesLoadedMicrosoft Exchange
+8 more
MySQLPrimeNGMicrosoft 365 Apps & ServicesMobile FriendlyLoopiaOpen GraphjQueryRSS
- Sector
- Research
- Industry code
- NAICS 541714, 325412, SIC 2834
- Region
- Vaestra Goetaland County
- Full record
- Every detail in the company directory
Research in Sweden
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Empros Pharma in front of investors. Or tell us what we have wrong.